Non-invasive assessment of alzheimer's disease
AssigneeEnigma Biointelligence, Inc.
InventorsMichael Reitermann, Thomas H. Tulip, Mathotaarachchilage Sulantha Sanjeewa Mathotaarachchi
Life of this patent
Estimating the term…
Abstract
The present disclosure generally to non-invasive methods and tests that measure biomarkers and collect clinical parameters from subjects, and computer-implemented processes for assessing a likelihood that a patient has or will develop Alzheimer's Disease, e.g., by assigning the subject an Alzheimer's Disease risk score.
Claims115
A method for scoring a subject's risk for developing or already having Alzheimer's disease (AD), comprising:
- (a) receiving a dataset associated with the subject, wherein said dataset comprises quantitative data for at least 4 protein markers in one or more fluid samples from the subject, optionally wherein:
- (i) the fluid samples are selected from blood and cerebral spinal fluid (CSF);
- and/or
- (ii) the protein markers comprise at least 3 of a tau peptide marker, an amyloid peptide marker, a neurodegeneration marker, a metabolic disorder marker, and an inflammation marker;
- (b) generating an AD risk score from said dataset, thereby scoring the subject's risk for developing or already having AD.
A method of analyzing a sample from a subject comprising the steps of:
- (a) obtaining one or more fluid samples from a subject, optionally wherein the fluid samples are selected from blood and cerebral spinal fluid (CSF);
- (b) performing an antibody or antigen assay on the one or more fluid samples to measure the levels of at least 4 protein markers, optionally wherein the protein markers comprise at least 3 of a tau peptide marker, an amyloid peptide marker, a neurodegeneration marker, a metabolic disorder marker, and an inflammation marker;
- (c) generating quantitative values of the at least 4 protein markers;
- (d) storing the quantitative values in a dataset associated with the subject;
- and
- (e) generating an AD risk score from the dataset, thereby analyzing the sample from the subject.
A computer implemented method for assessing a subject's risk for developing or already having AD, the method comprising executing, in a computer system having one or more processors coupled to a memory storing one or more computer readable instructions for execution by the one or more processors, the one or more computer readable instructions comprising instructions for:
- (a) storing a dataset associated with the subject, wherein said dataset comprises quantitative data for at least 4 protein markers in one or more fluid samples from the subject, wherein:
- (i) the fluid samples are selected from blood and cerebral spinal fluid (CSF);
- and/or
- (ii) the protein markers comprise at least 3 of a tau peptide marker, an amyloid peptide marker, a neurodegeneration marker, a metabolic disorder marker, and an inflammation marker;
- and
- (b) generating an AD risk score for the subject from the dataset, thereby scoring the subject's risk for developing or already having AD.
A method of producing an artificial intelligence-based algorithm for generating an AD risk score for a subject, the method comprising executing, in a computer system having one or more processors coupled to a memory storing one or more computer readable instructions for execution by the one or more processors, the one or more computer readable instructions comprising instructions for:
- (a) storing a dataset comprising a plurality of patient records, each patient record comprising quantitative data for at least 4 protein markers in one or more fluid samples from the patient and data for one or more AD surrogate variables for the patient, wherein:
- (i) the fluid samples are selected from blood and cerebral spinal fluid (CSF);
- and/or
- (ii) the protein markers comprise at least 3 of a tau peptide marker, an amyloid peptide marker, a neurodegeneration marker, a metabolic disorder marker, and an inflammation marker;
- and
- (b) training a machine learning model with at least a portion of the patient records, wherein the quantitative data for the at least 4 protein markers are input variables and the data for the AD surrogate variable are output variables for the machine learning model, thereby providing an artificial intelligence-based algorithm for generating an AD risk score.
A system for generating an AD risk score for a subject, comprising one or more processors coupled to a memory storing one or more computer readable instructions for execution by the one or more processors, the one or more computer readable instructions comprising instructions for:
- (a) storing a dataset comprising a plurality of patient records, each patient record comprising quantitative data for at least 4 protein markers in one or more fluid samples from the patient and data for one or more AD surrogate variables for the patient, wherein:
- (i) the fluid samples are selected from blood and cerebral spinal fluid (CSF);
- and/or
- (ii) the protein markers comprise at least 3 of a tau peptide marker, an amyloid peptide marker, a neurodegeneration marker, a metabolic disorder marker, and an inflammation marker;
- (b) training a machine learning model with at least a portion of the patient records, wherein the quantitative data for the at least 4 protein markers are input variables and the data for the AD surrogate variable are output variables for the machine learning model to produce an AI-based algorithm for generating an AD risk score;
- (c) generating an AD risk score for the subject using the AI-based algorithm;
- (d) classifying the subject as having a low risk of developing AD if the AD risk score indicates that the subject is at a low risk of developing AD, having a medium (or moderate) risk of developing AD if the AD risk score indicates that the subject is at medium (or moderate) risk of developing AD, or high risk of having or developing AD if the AD risk score indicates that the subject is at high risk of having or developing AD;
- and
- (e) generating a report comprising a representation of the risk category into which the has been classified and/or a recommendation for the subject based on the subject's classification.
Dependencies are inferred from the claim text.